Published in Vaccine Weekly, November 7th, 2001
In traditional vaccine approaches, researchers have used live, weakened or dead pathogens - or proteins produced by the organisms - to produce an immune response.
"The current work is a strong argument for the feasibility of using a DNA-based immunization strategy against anthrax."
This new approach represents a new - and perhaps, safer - way to produce vaccines against highly contagious diseases. This latest study, published in the journal Infection and Immunity, improves on...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2001-11-07)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.